Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Blueprint Medicines Corporation a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on…